Data-Powered Plant Intelligence for Food Supplements & Plant-Based Medicines
Patent Co-Dev Platform
At Vivaltes, we integrate original AI solutions with ethical laboratory validation to discover plant health benefits, patent ingredient blends, and enhance health products.
Our vision is clear:- Accelerate discovery
- Develop patents
- Elevate your product
Supported by
Patent Co-Dev Platform
Data-Powered Plant Intelligence for Food Supplements & Plant-Based Medicines
- 14,000 Plants in Platform
- 4-6 weeks Per Compound
- 70-80% savings vs. Animal Models
From plant insight to filed patents
The only bundled co-development programme combining a 14,000-plant predictive platform with ethical C. elegans testing to turn R&D spend into registered IP assets.
-
Single Preclinical Run
Toxicity & efficacy predicted simultaneously — no separate studies, no duplicated cost.
-
Platform-First Intelligence
14,000-plant compound database predicts bioactive behaviour before any lab spend.
-
IP as the Output
R&D investment converts directly into a filed, registered patent asset co-owned by client.
-
EFSA Health Claims Ready
Data package structured to support regulatory submissions and health claims out of the box.
Track record & value generated
-
Nutraceutical SME (Cognitive Health, Endurance) · BUILD
5 patents filed in 14 months
Active R&D portfolio, no animal-free testing infrastructure, EFSA submission pending
Novel products for endurance & cognitive health, improved delivery methodologies, and toxicity testing strategy for complex chemicals filed within 14 months of programme start. Discovery stage → Preclinical → Regulatory filing.
-
Mid-Size (Healthy Lifestyle) · SCALE
50% of compounds already filed
Multiple legacy compounds, accelerated path to clinical trials
Full assessment of client’s legacy compounds powered by data analytics prediction, chemical optimization and biological animal-free testing. Validation of a shortlist of 14 high-value compounds eligible for patenting. 50% were patented right afterwards.
-
Plant-Based Medicine SME (Healthy Ageing) · BUILD
4 patents filed in 14 months
Multiple candidate compounds, preclinical data and international filing ambition
Non-clinical development → international IP protection for endurance, regulation of appetite and sport recovery.
-
Biotech Start-Ups (Animal Health) · SEED → BUILD
Series A/B+ raised on co-owned IP
Pre-Series A, needed IP assets to anchor investor deck and justify valuation
Upsell from Seed to Build after Year 1. Co-developed IP now forms the basis of the Series A fundraising deck. Discovery → Non-clinical → IP-backed fundraise.
Patent co-development programme - "Commercial offers"
- Annuel Bundle Offer
- All Tiers Include Platform + C. elegans Testing
-
SEED
Deep-tech start-ups · early pipelineWhat's included
- 2 compounds via plant data platform
- 2–4 C. elegans runs (toxicity + efficacy)
- Patent opportunity identification
- Platform read access for compound prediction
- Quarterly data & progress report
- IP: client holds primary rights
-
BUILD
Innovative SMEs · active R&D portfolioWhat's included
- 5–6 compounds assessed per year
- Quarterly C. elegans runs — toxicity, efficacy & dose-response
- Patent co-development
- Full platform access incl. data export & comparison
- Regulatory documentation support
- Monthly reporting + dedicated scientific contact
- IP: co-ownership, exclusive commercial rights
-
SCALE
Mid-sized enterprises · outsourced R&DWhat's included
- 10+ compounds assessed per year
- Dedicated C. elegans capacity — priority scheduling
- Patent co-development + PCT/international filing
- Full platform API access + white-label reporting
- Scientific publication co-authorship rights
- Dedicated team · bi-weekly syncs · R&D roadmap
- IP: negotiated co-IP + milestone payments
Partnership will include either a share of sales or fixed milestone payments when patents are licensed or approved, as agreed by both sides.
How will you innovate the future of health products?
Join Vivaltes in shaping the future of health. Whether you’re developing nutraceuticals, plant-based medicines, searching for the next breakthrough in supplement marketing, or seeking ethical testing alternatives, our expertise and cutting-edge technologies are here to support you.